BIO.News Newsletter

On the anniversary of the COVID-19 “pandemic,” we look back on how far we’ve come and where we go from here. (936 words, 4 minutes, 40 seconds)

A bipartisan bill would replace banned Russian oil with American biofuels—and the U.S. already has much of the capacity we need. And, it’s World Kidney Day, so we provide resources and explore the links between kidney disease and climate change. (738 words, 3 minutes, 41 seconds)

We take a closer look at how the biotech industry is responding to Ukraine and why the EU might lift its ban on imports of GMO grains, plus recap yesterday’s House hearing on SBIR/STTR, all the way at the end. (902 words, 4 minutes, 30 seconds)

Happy International Women’s Day. Today, we look at FDA’s decision on gene-edited cattle for food and CEPI’s economic case for pandemic preparedness. (773 words, 3 minutes, 51 seconds)

We look at the links between the conflict in Ukraine and the sustainability of our energy and food supply—and the important role for biotech in ensuring the stability of our world’s resources. Also, it’s officially 100 days until the BIO International Convention—back in person! (632 words, 3 minutes, 9 seconds)

A new report explains how policy can boost vaccination in the U.S., and a plant pandemic could be closer than we think. (573 words, 2 minutes, 51 seconds)

BIO’s joining efforts to support the people of Ukraine—here’s how you can help. Plus, we discuss the outlook for Alzheimer’s breakthroughs and advice for women founders of patient advocacy organizations. (743 words, 3 minutes, 42 seconds)

Everything you need to know about Biden’s State of the Union—plus two U.S. Senators weighed in on the CMS Alzheimer’s decision and Dr. Julie Gerberding’s big news. (847 words, 4 minutes, 14 seconds)

Will President Biden talk about drug price controls during the State of the Union? We’ll find out tonight. Plus, the new IPCC report says climate change is happening faster than we thought—but thanks to biotech, adaptation is already underway. (548 words, 2 minutes, 44 seconds)

On Rare Disease Day, we look at a new report that shows the economic burden of rare disease—and the value of investing in new treatments. Plus, we recap what one BIO Board member said about animal genomics during last week’s USDA Agricultural Outlook Forum. (659 words, 3 minutes, 17 seconds)